A novel type-2 innate lymphoid cell-based immunotherapy for cancer by Iryna Saranchova, Iryna Saranchova, Iryna Saranchova, Iryna Saranchova, Iryna Saranchova, Iryna Saranchova, Iryna Saranchova, Clara Wenjing Xia, Clara Wenjing Xia, Clara Wenjing Xia, Clara Wenjing Xia, Clara Wenjing Xia, Clara Wenjing Xia, Clara Wenjing Xia, Stephanie Besoiu, Stephanie Besoiu, Stephanie Besoiu, Stephanie Besoiu, Stephanie Besoiu, Stephanie Besoiu, Stephanie Besoiu, Pablo L. Finkel, Pablo L. Finkel, Pablo L. Finkel, Pablo L. Finkel, Pablo L. Finkel, Pablo L. Finkel, Pablo L. Finkel, Samantha L. S. Ellis, Samantha L. S. Ellis, Samantha L. S. Ellis, Samantha L. S. Ellis, Samantha L. S. Ellis, Samantha L. S. Ellis, Samantha L. S. Ellis, Suresh Kari, Suresh Kari, Suresh Kari, Suresh Kari, Suresh Kari, Suresh Kari, Suresh Kari, Lonna Munro, Lonna Munro, Lonna Munro, Lonna Munro, Lonna Munro, Lonna Munro, Lonna Munro, Cheryl G. Pfeifer, Cheryl G. Pfeifer, Cheryl G. Pfeifer, Cheryl G. Pfeifer, Cheryl G. Pfeifer, Cheryl G. Pfeifer, Cheryl G. Pfeifer, Ladan Fazli, Ladan Fazli, Martin E. Gleave, Martin E. Gleave, Wilfred A. Jefferies, Wilfred A. Jefferies, Wilfred A. Jefferies, Wilfred A. Jefferies, Wilfred A. Jefferies, Wilfred A. Jefferies, Wilfred A. Jefferies

Get full text

A diversity of novel type-2 innate lymphoid cell subpopulations revealed during tumour expansion by Clara Wenjing Xia, Iryna Saranchova, Pablo L. Finkel, Stephanie Besoiu, Lonna Munro, Cheryl G. Pfeifer, Anne Haegert, Yen-Yi Lin, Stéphane Le Bihan, Colin Collins, Wilfred A. Jefferies

Get full text